SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 18, 2002
(Exact name of registrant as specified in its charter) |
| 0-19153 | 06-1192468 |
| (Commission File Number) | (I.R.S. Employer Identification No.) |
| 9 Parker, Irvine, California | 92618-1605 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (949) 470-9011
Item 5. Other Events.
Included as Exhibit 99.1 is a press release entitled “Nexell Therapeutics Files Certificate of Dissolution” issued by Nexell Therapeutics Inc. on December 18, 2002.
Item 7. Financial Statements and Exhibits.
The following exhibits are filed as a part of this report:
| Exhibit No | |
| 99.1 | Press release of Nexell Therapeutics Inc. dated December 18, 2002 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NEXELL THERAPEUTICS INC. | |
| Date: December 18, 2002 | By: /s/ Victor W. Schmitt |
| Victor W. Schmitt | |
| Chief Executive Officer and Chief Financial Officer |
EXHIBIT INDEX
| Exhibit No | ||
| 99.1 | Press release of Nexell Therapeutics Inc. dated December 18, 2002 | Filed herewith. |
